The latest announcement is out from PDS Biotechnology ( (PDSB) ).

Explore Vir Biotechnology (NASDAQ: VIR) operations in the healthcare sector and its presence in S&P 500, Nasdaq Composite, and Russell 1000 indexes, with detailed sector insights.

University of Liverpool and Newcastle researchers have uncovered how bacterial organelles assemble, opening new routes for ...

Prospera Financial Services acquires Regeneron Pharmaceuticals (REGN) shares, reflecting healthcare sector activity aligned ...

Translational study shows that multiple immunological biomarkers predict the clinical activity of PDS0101 combination therapy PDS01ADC reprograms ...

A low-intensity ultrasound treatment clears neurotoxic debris from the brains of mice with induced bleeding that resembles a ...

Today is shaping up negative for Vir Biotechnology, Inc. ( NASDAQ:VIR ) shareholders, with the analysts delivering ...

INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today ...

Recognizing the ongoing China International Import Expo (CIIE) in Shanghai as a globally prominent platform and a vital ...

The biotechnology sector continues to demonstrate its unforgiving nature as Ocugen navigates turbulent financial waters while ...

Researchers are working on microscopic, wireless chips that can travel through the bloodstream and self-implant in a targeted ...

Cephalopods like octopuses, squid, and cuttlefish have the mesmerizing ability to change the color of their skin to ...